Cargando…
Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium
PURPOSE: The objective of this study was to assess the efficacy and safety of pembrolizumab in combination with standard carboplatin/paclitaxel in patients with advanced endometrial cancer. PATIENTS AND METHODS: This single-arm, open-label, multicenter phase II study enrolled patients with RECIST me...
Autores principales: | Barber, Emma L., Chen, Siqi, Pineda, Mario Javier, Robertson, Sharon E., Hill, Emily K., Teoh, Deanna, Schilder, Jeanne, O'Shea, Kaitlyn L., Kocherginsky, Masha, Zhang, Bin, Matei, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648489/ https://www.ncbi.nlm.nih.gov/pubmed/36388466 http://dx.doi.org/10.1158/2767-9764.CRC-22-0147 |
Ejemplares similares
-
Identification of the toxic 6mer seed consensus for human cancer cells
por: Patel, Monal, et al.
Publicado: (2022) -
Ten simple rules for a successful international consortium in big data omics
por: Stobbe, Miranda D., et al.
Publicado: (2022) -
Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer
por: Keathley, Russell, et al.
Publicado: (2023) -
SPOROS: A pipeline to analyze DISE/6mer seed toxicity
por: Bartom, Elizabeth T., et al.
Publicado: (2022) -
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
por: Karrison, Theodore, et al.
Publicado: (2018)